{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:55:05Z","timestamp":1782982505609,"version":"3.54.5"},"reference-count":86,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["anesthesiology.theclinics.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anesthesiology Clinics"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.anclin.2016.04.010","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T03:45:17Z","timestamp":1470800717000},"page":"601-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neuromuscular Disease in\u00a0the Neurointensive Care Unit"],"prefix":"10.1016","volume":"34","author":[{"given":"Veronica","family":"Crespo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"\u201cLuke\u201dJames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.anclin.2016.04.010_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/mus.23817","article-title":"Neuromuscular disease and anesthesia","volume":"48","author":"Romero","year":"2013","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.anclin.2016.04.010_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1399-6576.2011.02558.x","article-title":"Anesthesia and myasthenia gravis","volume":"56","author":"Blichfeldt-Lauridsen","year":"2012","journal-title":"Acta Anaesthesiol Scand"},{"issue":"5","key":"10.1016\/j.anclin.2016.04.010_bib3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jclinane.2013.01.017","article-title":"Repeated spinal anesthesia in a tetraparetic patient with Guillain-Barre syndrome","volume":"25","author":"Wipfli","year":"2013","journal-title":"J\u00a0Clin Anesth"},{"issue":"3","key":"10.1016\/j.anclin.2016.04.010_bib4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1213\/00000539-198903000-00046","article-title":"Epidural anesthesia for patients with amyotrophic lateral sclerosis","volume":"68","author":"Kochi","year":"1989","journal-title":"Anesth Analg"},{"issue":"11","key":"10.1016\/j.anclin.2016.04.010_bib5","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/EJA.0b013e32833e263f","article-title":"Myasthenia gravis and pregnancy: anaesthetic management\u2013a series of cases","volume":"27","author":"Almeida","year":"2010","journal-title":"Eur J Anaesthesiol"},{"issue":"6","key":"10.1016\/j.anclin.2016.04.010_bib6","first-page":"909","article-title":"Anesthetic management of the patient with amyotrophic lateral sclerosis","volume":"27","author":"Prabhakar","year":"2013","journal-title":"J\u00a0Anesth"},{"issue":"9497","key":"10.1016\/j.anclin.2016.04.010_bib7","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barre syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.anclin.2016.04.010_bib8","article-title":"Plasma exchange for Guillain-Barre syndrome","author":"Raphael","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"8382","key":"10.1016\/j.anclin.2016.04.010_bib9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0140-6736(84)91341-2","article-title":"Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy","volume":"1","author":"Greenwood","year":"1984","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.anclin.2016.04.010_bib10","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.35.8.1096","article-title":"Plasmapheresis and acute Guillain-Barre syndrome. The Guillain-Barre syndrome Study Group","volume":"35","year":"1985","journal-title":"Neurology"},{"issue":"8415","key":"10.1016\/j.anclin.2016.04.010_bib11","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0140-6736(84)90819-5","article-title":"Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy","volume":"2","author":"Osterman","year":"1984","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.anclin.2016.04.010_bib12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.410220612","article-title":"Efficiency of plasma exchange in Guillain-Barre syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barre syndrome","volume":"22","year":"1987","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.anclin.2016.04.010_bib13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.410410304","article-title":"Appropriate number of plasma exchanges in Guillain-Barre syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barre Syndrome","volume":"41","year":"1997","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.anclin.2016.04.010_bib14","article-title":"Intravenous immunoglobulin for Guillain-Barre syndrome","author":"Hughes","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"9047","key":"10.1016\/j.anclin.2016.04.010_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Plasma Exchange\/Sandoglobulin Guillain-Barre Syndrome Trial Group","volume":"349","year":"1997","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.anclin.2016.04.010_bib16","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A\u00a0randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group","volume":"326","author":"van der Meche","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.anclin.2016.04.010_bib17","article-title":"Corticosteroids for Guillain-Barre syndrome","author":"Hughes","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.anclin.2016.04.010_bib18","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/archneur.62.8.1194","article-title":"Supportive care for patients with Guillain-Barre syndrome","volume":"62","author":"Hughes","year":"2005","journal-title":"Arch Neurol"},{"issue":"9","key":"10.1016\/j.anclin.2016.04.010_bib19","first-page":"1065","article-title":"Neuromuscular disease in respiratory and critical care medicine","volume":"51","author":"Hill","year":"2006","journal-title":"Respir Care"},{"issue":"4","key":"10.1016\/j.anclin.2016.04.010_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009950.pub3","article-title":"Pharmacological treatment for pain in Guillain-Barre syndrome","author":"Liu","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.anclin.2016.04.010_bib21","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/00000539-200212000-00046","article-title":"Gabapentin for the treatment of pain in Guillain-Barre syndrome: a double-blinded, placebo-controlled, crossover study","volume":"95","author":"Pandey","year":"2002","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.anclin.2016.04.010_bib22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1213\/01.ANE.0000152186.89020.36","article-title":"The comparative evaluation of gabapentin and carbamazepine for pain management in Guillain-Barre syndrome patients in the intensive care unit","volume":"101","author":"Pandey","year":"2005","journal-title":"Anesth Analg"},{"issue":"10","key":"10.1016\/j.anclin.2016.04.010_bib23","first-page":"1318","article-title":"Determination of pain and response to methylprednisolone in Guillain-Barre syndrome","volume":"254","author":"Ruts","year":"2007","journal-title":"J\u00a0Neurol"},{"issue":"8","key":"10.1016\/j.anclin.2016.04.010_bib24","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0003-9993(97)90203-3","article-title":"Rehabilitation of Guillain-Barre syndrome","volume":"78","author":"Meythaler","year":"1997","journal-title":"Arch Phys Med Rehabil"},{"issue":"9769","key":"10.1016\/j.anclin.2016.04.010_bib25","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.anclin.2016.04.010_bib26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1474-4422(07)70244-2","article-title":"Clinical care of patients with amyotrophic lateral sclerosis","volume":"6","author":"Radunovic","year":"2007","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.anclin.2016.04.010_bib27","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/WCO.0000000000000135","article-title":"The evidence for symptomatic treatments in amyotrophic lateral sclerosis","volume":"27","author":"Jenkins","year":"2014","journal-title":"Curr Opin Neurol"},{"issue":"8","key":"10.1016\/j.anclin.2016.04.010_bib28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tins.2014.05.006","article-title":"Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies","volume":"37","author":"Vucic","year":"2014","journal-title":"Trends Neurosci"},{"issue":"8","key":"10.1016\/j.anclin.2016.04.010_bib29","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI25424","article-title":"Antisense oligonucleotide therapy for neurodegenerative disease","volume":"116","author":"Smith","year":"2006","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.anclin.2016.04.010_bib30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.anclin.2016.04.010_bib31","doi-asserted-by":"crossref","first-page":"e97803","DOI":"10.1371\/journal.pone.0097803","article-title":"Safety, pharmacokinetic, and functional effects of the nogo\u2014a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial","volume":"9","author":"Meininger","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.anclin.2016.04.010_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001447.pub3","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","author":"Miller","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.anclin.2016.04.010_bib33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(05)70326-4","article-title":"Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial","volume":"5","author":"Bourke","year":"2006","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.anclin.2016.04.010_bib34","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/thx.2011.160481","article-title":"Home tracheotomy mechanical ventilation in patients with amyotrophic lateral sclerosis: causes, complications and 1-year survival","volume":"66","author":"Sancho","year":"2011","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.anclin.2016.04.010_bib35","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/jnnp.2009.175984","article-title":"Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy","volume":"81","author":"Chio","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.anclin.2016.04.010_bib36","doi-asserted-by":"crossref","first-page":"329.e7","DOI":"10.1016\/j.jcrc.2010.06.003","article-title":"Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis","volume":"26","author":"Vianello","year":"2011","journal-title":"J\u00a0Crit Care"},{"issue":"3","key":"10.1016\/j.anclin.2016.04.010_bib37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.amjsurg.2013.08.039","article-title":"Final analysis of the pilot trial of diaphragm pacing in amyotrophic lateral sclerosis with long-term follow-up: diaphragm pacing positively affects diaphragm respiration","volume":"207","author":"Onders","year":"2014","journal-title":"Am J Surg"},{"issue":"9","key":"10.1016\/j.anclin.2016.04.010_bib38","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S1474-4422(15)00152-0","article-title":"Safety and efficacy of diaphragm pacing in patients with respiratory insufficiency due to amyotrophic lateral sclerosis (DiPALS): a multicentre, open-label, randomised controlled trial","volume":"14","author":"McDermott","year":"2015","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.anclin.2016.04.010_bib39","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00455-014-9535-8","article-title":"The use of botulinum toxin injections to manage drooling in amyotrophic lateral sclerosis\/motor neurone disease: a systematic review","volume":"29","author":"Squires","year":"2014","journal-title":"Dysphagia"},{"issue":"3","key":"10.1016\/j.anclin.2016.04.010_bib40","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijrobp.2013.11.230","article-title":"Radiation therapy for hypersalivation: a prospective study in 50 amyotrophic lateral sclerosis patients","volume":"88","author":"Assouline","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.anclin.2016.04.010_bib41","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/01.WNL.0000092018.56823.02","article-title":"Cough augmentation in amyotrophic lateral sclerosis","volume":"61","author":"Mustfa","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.anclin.2016.04.010_bib42","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1378\/chest.125.4.1400","article-title":"Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis","volume":"125","author":"Sancho","year":"2004","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.anclin.2016.04.010_bib43","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/01.PHM.0000087456.28979.2E","article-title":"Mechanical insufflation-exsufflation vs. tracheal suctioning via tracheostomy tubes for patients with amyotrophic lateral sclerosis: a pilot study","volume":"82","author":"Sancho","year":"2003","journal-title":"Am J Phys Med Rehabil"},{"issue":"6","key":"10.1016\/j.anclin.2016.04.010_bib44","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1212\/01.wnl.0000237439.78935.46","article-title":"High-frequency chest wall oscillation in ALS: an exploratory randomized, controlled trial","volume":"67","author":"Lange","year":"2006","journal-title":"Neurology"},{"issue":"7\u20138","key":"10.1016\/j.anclin.2016.04.010_bib45","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/21678421.2013.812659","article-title":"Outcome of percutaneous endoscopic gastrostomy insertion in patients with amyotrophic lateral sclerosis in relation to respiratory dysfunction","volume":"14","author":"Sarfaty","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"5","key":"10.1016\/j.anclin.2016.04.010_bib46","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4187\/respcare.02024","article-title":"Outcomes of percutaneous endoscopic gastrostomy tube insertion in respiratory impaired amyotrophic lateral sclerosis patients under noninvasive ventilation","volume":"58","author":"Czell","year":"2013","journal-title":"Respir Care"},{"issue":"7","key":"10.1016\/j.anclin.2016.04.010_bib47","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1474-4422(15)00104-0","article-title":"Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study","volume":"14","year":"2015","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.anclin.2016.04.010_bib48","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.clinph.2014.06.031","article-title":"Lambert-Eaton myasthenic syndrome\u2014diagnosis, pathogenesis and therapy","volume":"125","author":"Hulsbrink","year":"2014","journal-title":"Clin Neurophysiol"},{"issue":"950","key":"10.1016\/j.anclin.2016.04.010_bib49","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/pgmj.2004.018903","article-title":"Update on myasthenia gravis","volume":"80","author":"Thanvi","year":"2004","journal-title":"Postgrad Med J"},{"issue":"10","key":"10.1016\/j.anclin.2016.04.010_bib50","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/11593300-000000000-00000","article-title":"Treatment of myasthenia gravis: focus on pyridostigmine","volume":"31","author":"Maggi","year":"2011","journal-title":"Clin Drug Investig"},{"issue":"1","key":"10.1016\/j.anclin.2016.04.010_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.anclin.2016.04.010_bib52","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cei.12217","article-title":"Myasthenia gravis: an update for the clinician","volume":"175","author":"Sieb","year":"2014","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.anclin.2016.04.010_bib53","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","article-title":"A\u00a0randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group","volume":"50","author":"Palace","year":"1998","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.anclin.2016.04.010_bib54","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ncpneuro0810","article-title":"Steroids and immunosuppressant drugs in myasthenia gravis","volume":"4","author":"Sathasivam","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"issue":"9","key":"10.1016\/j.anclin.2016.04.010_bib55","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.autrev.2013.03.004","article-title":"Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase","volume":"12","author":"Evoli","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.anclin.2016.04.010_bib56","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/mus.24063","article-title":"Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment","volume":"48","author":"Yi","year":"2013","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.anclin.2016.04.010_bib57","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/jnnp.2010.220475","article-title":"Use and monitoring of low dose rituximab in myasthenia gravis","volume":"82","author":"Blum","year":"2011","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.anclin.2016.04.010_bib58","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/jnnp-2012-303664","article-title":"Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients","volume":"84","author":"Keung","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.anclin.2016.04.010_bib59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.0b013e3182407982","article-title":"Long-lasting treatment effect of rituximab in MuSK myasthenia","volume":"78","author":"Diaz-Manera","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.anclin.2016.04.010_bib60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/WNL.55.1.7","article-title":"Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology","volume":"55","author":"Gronseth","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.anclin.2016.04.010_bib61","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11940-014-0283-8","article-title":"Treatment of MuSK-associated myasthenia gravis","volume":"16","author":"El-Salem","year":"2014","journal-title":"Curr Treat Options Neurol"},{"issue":"11","key":"10.1016\/j.anclin.2016.04.010_bib62","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/01.wnl.0000256698.69121.45","article-title":"IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial","volume":"68","author":"Zinman","year":"2007","journal-title":"Neurology"},{"issue":"23","key":"10.1016\/j.anclin.2016.04.010_bib63","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0b013e31821e5505","article-title":"Comparison of IVIg and PLEX in patients with myasthenia gravis","volume":"76","author":"Barth","year":"2011","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.anclin.2016.04.010_bib64","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/archneur.62.11.1689","article-title":"Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial","volume":"62","author":"Gajdos","year":"2005","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.anclin.2016.04.010_bib65","first-page":"112","article-title":"Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy\/myopathy in critically ill patients","volume":"29","author":"Apostolakis","year":"2015","journal-title":"J\u00a0Anesth"},{"issue":"9","key":"10.1016\/j.anclin.2016.04.010_bib66","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1164\/rccm.201107-1320OE","article-title":"Neuromuscular blockade and skeletal muscle weakness in critically ill patients: time to rethink the evidence?","volume":"185","author":"Puthucheary","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anclin.2016.04.010_bib67","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/mus.20304","article-title":"Neuromuscular manifestations of critical illness","volume":"32","author":"Bolton","year":"2005","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.anclin.2016.04.010_bib68","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1097\/00003246-200112000-00008","article-title":"Risk factors for the development of polyneuropathy and myopathy in critically ill patients","volume":"29","author":"de Letter","year":"2001","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.anclin.2016.04.010_bib69","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-0404.2008.00996.x","article-title":"Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit","volume":"118","author":"Nanas","year":"2008","journal-title":"Acta Neurol Scand"},{"issue":"16","key":"10.1016\/j.anclin.2016.04.010_bib70","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa051693","article-title":"Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome","volume":"354","author":"Steinberg","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.anclin.2016.04.010_bib71","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMoa022450","article-title":"One-year outcomes in survivors of the acute respiratory distress syndrome","volume":"348","author":"Herridge","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.anclin.2016.04.010_bib72","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1001\/jama.288.22.2859","article-title":"Paresis acquired in the intensive care unit: a prospective multicenter study","volume":"288","author":"De Jonghe","year":"2002","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.anclin.2016.04.010_bib73","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1212\/01.WNL.0000158442.08857.FC","article-title":"Insulin therapy protects the central and peripheral nervous system of intensive care patients","volume":"64","author":"Van den Berghe","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.anclin.2016.04.010_bib74","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1164\/rccm.200605-665OC","article-title":"Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit","volume":"175","author":"Hermans","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.anclin.2016.04.010_bib75","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/MRR.0b013e32834d32c7","article-title":"Rehabilitation of critical illness polyneuropathy and myopathy patients: an observational study","volume":"34","author":"Novak","year":"2011","journal-title":"Int J Rehabil Res"},{"issue":"6","key":"10.1016\/j.anclin.2016.04.010_bib76","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4187\/respcare.01634","article-title":"Critical illness neuromyopathy and the role of physical therapy and rehabilitation in critically ill patients","volume":"57","author":"Fan","year":"2012","journal-title":"Respir Care"},{"issue":"3","key":"10.1016\/j.anclin.2016.04.010_bib77","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/NPT.0b013e3182275905","article-title":"Physical therapy management and patient outcomes following ICU-acquired weakness: a case series","volume":"35","author":"Nordon-Craft","year":"2011","journal-title":"J\u00a0Neurol Phys Ther"},{"issue":"9","key":"10.1016\/j.anclin.2016.04.010_bib78","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1097\/CCM.0b013e3181a38937","article-title":"Early exercise in critically ill patients enhances short-term functional recovery","volume":"37","author":"Burtin","year":"2009","journal-title":"Crit Care Med"},{"issue":"9678","key":"10.1016\/j.anclin.2016.04.010_bib79","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/S0140-6736(09)60658-9","article-title":"Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial","volume":"373","author":"Schweickert","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.anclin.2016.04.010_bib80","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/cc8987","article-title":"Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial","volume":"14","author":"Routsi","year":"2010","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.anclin.2016.04.010_bib81","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nrneurol.2014.253","article-title":"Intravenous immunoglobulin in neurology\u2013mode of action and clinical efficacy","volume":"11","author":"Lunemann","year":"2015","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"10.1016\/j.anclin.2016.04.010_bib82","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/WCO.0b013e32830b0f61","article-title":"Plasma exchange in immune-mediated neuropathies","volume":"21","author":"Lehmann","year":"2008","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"10.1016\/j.anclin.2016.04.010_bib83","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/bjh.12629","article-title":"The mechanisms of action of plasma exchange","volume":"164","author":"Reeves","year":"2014","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.anclin.2016.04.010_bib84","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mus.23626","article-title":"Safety of plasma exchange therapy in patients with myasthenia gravis","volume":"47","author":"Ebadi","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.anclin.2016.04.010_bib85","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/asheducation.V2012.1.7.3797920","article-title":"Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines","volume":"2012","author":"Winters","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.anclin.2016.04.010_bib86","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/cc10312","article-title":"Give or take? Intravenous immunoglobulin or plasma exchange for Guillain-Barre syndrome","volume":"15","author":"Hughes","year":"2011","journal-title":"Crit Care"}],"container-title":["Anesthesiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1932227516300106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1932227516300106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T16:07:30Z","timestamp":1692461250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1932227516300106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1932227516300106"],"URL":"https:\/\/doi.org\/10.1016\/j.anclin.2016.04.010","relation":{},"ISSN":["1932-2275"],"issn-type":[{"value":"1932-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuromuscular Disease in\u00a0the Neurointensive Care Unit","name":"articletitle","label":"Article Title"},{"value":"Anesthesiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anclin.2016.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}